Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial

著者: Luciano J. Costa, Saurabh Chhabra, Eva Medvedova, Bhagirathbhai Dholaria, Timothy M. Schmidt, Kelly Godby, Rebecca Silbermann, Binod Dhakal, Susan Bal, Smith Giri, Anita D’Souza, Aric C. Hall, Pamela Hardwick, James Omel, Robert F. Cornell, Parameswaran Hari, Natalie S. Callander - The Lancet 2023 被引用: 150